Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT02443116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Study With Additional Open-label, Single-blind and Placebo-controlled Cohorts to Assess the Safety, Tolerability, and Efficacy of NGM282 in Patients With Nonalcoholic Steatohepatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety, tolerability, and efficacy of NGM282 in patients with nonalcoholic steatohepatitis.
Study identification
- NCT ID
- NCT02443116
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 254 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2015 (Actual)
- Primary completion
- Dec 6, 2019 (Actual)
- Completion
- Jan 17, 2020 (Actual)
- Last update posted
- Jul 23, 2025
2015 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NGM Clinical Study Site 922 | Chandler | Arizona | 85224 | — |
| NGM Clinical Study Site 923 | Tucson | Arizona | 85712 | — |
| NGM Clinical Study Site 924 | Los Angeles | California | 90057 | — |
| NGM Clinical Study Site 901 | San Diego | California | 92103 | — |
| NGM Clinical Study Site 902 | Denver | Colorado | — | — |
| NGM Clinical Study Site 917 | Lakewood Rch | Florida | 34211 | — |
| NGM Clinical Study Site 906 | Chicago | Illinois | 60611 | — |
| NGM Clinical Study Site 918 | Kansas City | Missouri | 64131 | — |
| NGM Clinical Study Site 903 | Durham | North Carolina | 27710 | — |
| NGM Clinical Study Site 921 | Germantown | Tennessee | 38138 | — |
| NGM Clinical Study Site 910 | Dallas | Texas | 75246 | — |
| NGM Clinical Study Site 920 | Rollingwood | Texas | 78746 | — |
| NGM Clinical Study Site 909 | San Antonio | Texas | 78229 | — |
| NGM Clinical Study Site 905 | San Antonio | Texas | 78234 | — |
| NGM Clinical Study Site 904 | Charlottesville | Virginia | 22908 | — |
| NGM Clinical Study Site 911 | Richmond | Virginia | 23226 | — |
| NGM Clinical Study Site 908 | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02443116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02443116 live on ClinicalTrials.gov.